Expert Ratings For Intellia Therapeutics
Expert Ratings For Intellia Therapeutics
Intellia Therapeutics的专家评级
A clear picture of Intellia Therapeutics...In the last three months, 7 analysts have published ratings on Intellia Therapeutics (NASDAQ:NTLA), offering a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有7位分析师公布了对Intellia Therapeutics（纳斯达克股票代码：NTLA）的评级，提供了从看涨到看跌的不同视角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated Intellia Therapeutics and provided 12-month price targets. The average target is $71.0, accompanied by a high estimate of $120.00 and a low estimate of $54.00. A 2.35% drop is evident in the current average compared to the previous average price target of $72.71.
分析师最近对Intellia Therapeutics进行了评估，并提供了12个月的目标股价。平均目标为71.0美元，最高估计值为120.00美元，低估值为54.00美元。与之前的平均目标股价72.71美元相比，目前的平均价格下降了2.35％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
A clear picture of Intellia Therapeutics...
通过对分析师...
登录免费看全文
登录/注册
资讯热榜
更新时间